Docebo Inc. Sales And Marketing Expense
Docebo Inc. (DCBO) reported Sales And Marketing Expense of $76.35 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2026-02-27
- Docebo Inc. sales and marketing expense for the quarter ending 2025-03-31 was $20.36M, a 23.87% increase year-over-year.
- Docebo Inc. sales and marketing expense for the quarter ending 2024-12-31 was $18.43M, a 14.03% increase year-over-year.
- Docebo Inc. sales and marketing expense for the quarter ending 2024-09-30 was $17.76M, a 9.48% increase year-over-year.
- Docebo Inc. sales and marketing expense for the quarter ending 2024-03-31 was $16.43M, a 2.02% decline year-over-year.
| Period end | Sales And Marketing Expense 3 month | Sales And Marketing Expense 6 month | Sales And Marketing Expense 9 month | Sales And Marketing Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $76.35M 40-F · filed 2026-02-27 | |||
| 2025-03-31 | $20.36M 6-K · filed 2025-05-09 | $38.79M derived: sum of 2 quarters · filed 2026-02-27 | $56.55M derived: sum of 3 quarters · filed 2026-02-27 | |
| 2024-12-31 | $18.43M derived: 40-F 12 month − 6-K 9 month · filed 2026-02-27 | $36.19M derived: sum of 2 quarters · filed 2026-02-27 | $69.52M 40-F · filed 2026-02-27 | |
| 2024-09-30 | $17.76M 6-K · filed 2024-11-08 | $51.09M 6-K · filed 2024-11-08 | ||
| 2024-03-31 | $16.43M 6-K · filed 2025-05-09 | $32.60M derived: sum of 2 quarters · filed 2025-05-09 | $48.82M derived: sum of 3 quarters · filed 2025-05-09 | $66.86M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $16.16M derived: 40-F 12 month − 6-K 9 month · filed 2025-02-28 | $32.38M derived: sum of 2 quarters · filed 2025-02-28 | $50.43M derived: sum of 3 quarters · filed 2025-02-28 | $67.20M 40-F · filed 2025-02-28 |
| 2023-09-30 | $16.22M 6-K · filed 2024-11-08 | $34.27M derived: sum of 2 quarters · filed 2024-11-08 | $51.04M 6-K · filed 2024-11-08 | $66.55M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $18.05M 6-K · filed 2023-08-10 | $34.82M 6-K · filed 2023-08-10 | $50.32M derived: sum of 3 quarters · filed 2024-05-10 | $65.85M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | $16.77M 6-K · filed 2024-05-10 | $32.28M derived: sum of 2 quarters · filed 2024-05-10 | $47.80M derived: sum of 3 quarters · filed 2024-05-10 | $62.68M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $15.50M derived: 40-F 12 month − 6-K 9 month · filed 2024-02-23 | $31.03M derived: sum of 2 quarters · filed 2024-02-23 | $45.91M derived: sum of 3 quarters · filed 2024-02-23 | $59.65M 40-F · filed 2024-02-23 |
| 2022-09-30 | $15.52M 6-K · filed 2023-11-09 | $30.40M derived: sum of 2 quarters · filed 2023-11-09 | $44.15M 6-K · filed 2023-11-09 | $56.79M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $14.88M 6-K · filed 2023-08-10 | $28.63M 6-K · filed 2023-08-10 | $41.27M derived: sum of 3 quarters · filed 2023-08-10 | $52.41M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $13.75M 6-K · filed 2023-05-11 | $26.39M derived: sum of 2 quarters · filed 2023-05-11 | $37.53M derived: sum of 3 quarters · filed 2023-05-11 | $47.97M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $12.64M derived: 40-F 12 month − 6-K 9 month · filed 2023-03-09 | $23.78M derived: sum of 2 quarters · filed 2023-03-09 | $34.23M derived: sum of 3 quarters · filed 2023-03-09 | $43.35M 40-F · filed 2023-03-09 |
| 2021-09-30 | $11.14M 6-K · filed 2022-11-10 | $21.59M derived: sum of 2 quarters · filed 2022-11-10 | $30.71M 6-K · filed 2022-11-10 | |
| 2021-06-30 | $10.45M 6-K · filed 2022-08-11 | $19.57M 6-K · filed 2022-08-11 | ||
| 2021-03-31 | $9.12M 6-K · filed 2022-05-12 | |||
| 2020-12-31 | $24.02M 40-F · filed 2022-03-10 | |||
| 2019-12-31 | $18.04M 40-F · filed 2021-03-11 |